These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1386612)

  • 1. Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
    Hammerberg C; Arend WP; Fisher GJ; Chan LS; Berger AE; Haskill JS; Voorhees JJ; Cooper KD
    J Clin Invest; 1992 Aug; 90(2):571-83. PubMed ID: 1386612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 and IL-1 receptor antagonist regulation during keratinocyte cell cycle and differentiation in normal and psoriatic epidermis.
    Hammerberg C; Bata-Csorgo Z; Voorhees JJ; Cooper KD
    Arch Dermatol Res; 1998 Jul; 290(7):367-74. PubMed ID: 9749991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes.
    Gruaz-Chatellard D; Baumberger C; Saurat JH; Dayer JM
    FEBS Lett; 1991 Dec; 294(1-2):137-40. PubMed ID: 1720743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.
    Groves RW; Sherman L; Mizutani H; Dower SK; Kupper TS
    Am J Pathol; 1994 Nov; 145(5):1048-56. PubMed ID: 7977638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 receptor antagonist production by human keratinocytes.
    Bigler CF; Norris DA; Weston WL; Arend WP
    J Invest Dermatol; 1992 Jan; 98(1):38-44. PubMed ID: 1530822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of interleukin 1 receptor antagonist in the stratum corneum of sun-exposed and ultraviolet B-irradiated human skin.
    Hirao T; Aoki H; Yoshida T; Sato Y; Kamoda H
    J Invest Dermatol; 1996 May; 106(5):1102-7. PubMed ID: 8618047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
    Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases.
    Terui T; Hirao T; Sato Y; Uesugi T; Honda M; Iguchi M; Matsumura N; Kudoh K; Aiba S; Tagami H
    Exp Dermatol; 1998 Dec; 7(6):327-34. PubMed ID: 9858135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counter-regulation of interleukin-1alpha (IL-1alpha) and IL-1 receptor antagonist in murine keratinocytes.
    Mee JB; Antonopoulos C; Poole S; Kupper TS; Groves RW
    J Invest Dermatol; 2005 Jun; 124(6):1267-74. PubMed ID: 15955103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 and interleukin-6 in psoriasis.
    Prens EP; Benne K; van Damme J; Bakkus M; Brakel K; Benner R; van Joost T
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis.
    Kristensen M; Deleuran B; Eedy DJ; Feldmann M; Breathnach SM; Brennan FM
    Br J Dermatol; 1992 Oct; 127(4):305-11. PubMed ID: 1419749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells.
    Arend WP; Coll BP
    Cytokine; 1991 Sep; 3(5):407-13. PubMed ID: 1836395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.
    Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG
    J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and secretion of interleukin-1 alpha and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes.
    Corradi A; Franzi AT; Rubartelli A
    Exp Cell Res; 1995 Apr; 217(2):355-62. PubMed ID: 7698236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium.
    Haskill S; Martin G; Van Le L; Morris J; Peace A; Bigler CF; Jaffe GJ; Hammerberg C; Sporn SA; Fong S
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3681-5. PubMed ID: 1827201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.
    Vannier E; Miller LC; Dinarello CA
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4076-80. PubMed ID: 1533284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions.
    Ohta Y; Katayama I; Funato T; Yokozeki H; Nishiyama S; Hirano T; Kishimoto T; Nishioka K
    Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.